Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-24-000352

President and CEO acquired 13,516 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fordyce Marshall · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-29 Exercise or conversion : show line 1 in the form +516 $2.32 $1,196 243,877 D
2023-12-29 Exercise or conversion : show line 2 in the form +13,000 $2.90 $37,658 256,877 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-12-29 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −516 0 D
2023-12-29 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −13,000 874,212 D
Loading xslF345X05/doc4.xml…